CA2343049A1 - Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose - Google Patents
Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose Download PDFInfo
- Publication number
- CA2343049A1 CA2343049A1 CA002343049A CA2343049A CA2343049A1 CA 2343049 A1 CA2343049 A1 CA 2343049A1 CA 002343049 A CA002343049 A CA 002343049A CA 2343049 A CA2343049 A CA 2343049A CA 2343049 A1 CA2343049 A1 CA 2343049A1
- Authority
- CA
- Canada
- Prior art keywords
- vitamin
- receptor
- gene
- genotype
- estrogen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10044698P | 1998-09-15 | 1998-09-15 | |
US60/100,446 | 1998-09-15 | ||
PCT/CA1999/000854 WO2000015836A2 (fr) | 1998-09-15 | 1999-09-15 | Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2343049A1 true CA2343049A1 (fr) | 2000-03-23 |
Family
ID=22279811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002343049A Abandoned CA2343049A1 (fr) | 1998-09-15 | 1999-09-15 | Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1114181A2 (fr) |
AU (1) | AU5723399A (fr) |
CA (1) | CA2343049A1 (fr) |
WO (1) | WO2000015836A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002006522A2 (fr) * | 2000-07-15 | 2002-01-24 | Signalgene Inc. | Marqueur du gene du recepteur de l'oestrogene permettant de determiner la predisposition a une densite osseuse faible |
US8296073B2 (en) | 2006-07-12 | 2012-10-23 | Progenika Biopharma, S.A. | Diagnostic method |
WO2008016155A1 (fr) * | 2006-07-31 | 2008-02-07 | The University Of Tokyo | Procédé de criblage d'un ligand du récepteur de la vitamine d |
CN111394452A (zh) * | 2020-04-23 | 2020-07-10 | 长沙金域医学检验实验室有限公司 | 基于探针法实现维D受体ApaI位点准确分型的引物组合物、试剂、检测方法和系统 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPM701594A0 (en) * | 1994-07-25 | 1994-08-18 | Garvan Institute Of Medical Research | Diagnostic method |
AUPN058895A0 (en) * | 1995-01-16 | 1995-02-09 | Garvan Institute Of Medical Research | Diagnostic method |
AU1299097A (en) * | 1996-01-25 | 1997-08-20 | Universite Laval | Marker at the estrogen receptor gene for determination of osteoporosis predisposition |
WO1997032998A2 (fr) * | 1996-03-08 | 1997-09-12 | Isis Innovation Limited | Materiels et procedes relatifs a l'identification d'un polymorphisme associe a une sensibilite a des pathologies |
US5698399A (en) * | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
-
1999
- 1999-09-15 EP EP99944190A patent/EP1114181A2/fr not_active Withdrawn
- 1999-09-15 CA CA002343049A patent/CA2343049A1/fr not_active Abandoned
- 1999-09-15 AU AU57233/99A patent/AU5723399A/en not_active Abandoned
- 1999-09-15 WO PCT/CA1999/000854 patent/WO2000015836A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5723399A (en) | 2000-04-03 |
WO2000015836A2 (fr) | 2000-03-23 |
WO2000015836A3 (fr) | 2000-06-08 |
EP1114181A2 (fr) | 2001-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4048053B2 (ja) | 特発性全身てんかんについてのローカス、当該ローカスのミューテーション、及びてんかんの評価、診断、予後、または治療のための当該ローカスの使用方法 | |
US5879884A (en) | Diagnosis of depression by linkage of a polymorphic marker to a segment of chromosome 19P13 bordered by D19S247 and D19S394 | |
EP1210426A2 (fr) | Polymorphismes dans un gene klotho | |
AU718326B2 (en) | Determination of collagen genotype | |
JP2002330758A (ja) | 化学化合物 | |
MXPA06012744A (es) | Marcadores de haplotipo y metodos para utilizarlos en la determinacion de la respuesta al tratamiento. | |
US20110038944A1 (en) | Compositions and methods for diagnosis and treatment of hepatobiliary disease and associated disorders | |
CA2343049A1 (fr) | Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose | |
AU1940001A (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
EP1282726A2 (fr) | Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants | |
JP2005278479A (ja) | 関節リウマチ検査用マーカー遺伝子 | |
US20060040263A1 (en) | Marker at the androgen receptor gene for determining breast cancer susceptibility | |
US20030008301A1 (en) | Association between schizophrenia and a two-marker haplotype near PILB gene | |
JP2008534019A (ja) | ヒトニーマンピックc1様1遺伝子(npc1l1)多型及びその使用方法 | |
WO2001073116A2 (fr) | Methode permettant de determiner la probabilite d'etre atteint d'osteoporose et/ou une faible densite osseuse, et reactifs destines a cette methode | |
WO2001081633A1 (fr) | Association de polymorphismes de la proteine kinase c zeta aux diabetes | |
CA2343572C (fr) | Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein | |
WO2002006522A2 (fr) | Marqueur du gene du recepteur de l'oestrogene permettant de determiner la predisposition a une densite osseuse faible | |
US20060211774A1 (en) | Method of diagnosins a genetic susceptibility for bone damage | |
WO1996017081A1 (fr) | Evaluation en vue d'un traitement par des agents neuroleptiques | |
WO2001078575A2 (fr) | $i(ext2) utilise comme marqueur predictif de l'osteoporose | |
JP2002521061A (ja) | ヒトのニューロキニン2受容体遺伝子における遺伝多型、並びに疾患の診断および処置におけるそれらの使用 | |
WO2001038586A2 (fr) | Acides nucleiques contenant des polymorphismes de nucleotides simples et methodes d'utilisation correspondantes | |
JP2001078773A (ja) | 骨粗鬆症薬剤感受性予測方法 | |
JP2007503806A (ja) | ヒト肥満感受性遺伝子およびその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |